Functional precision medicine works to take the guesswork out of deciding which drug to try next for patients with cancers that don’t respond to standard treatments.

There are many approaches to treating cancer. Which ones work best is determined on an individual basis and informed by each tumor.

The most common type of brain tumor in humans and dogs—called meningiomas—are extremely similar genetically, researchers report.

Glioblastoma is one of the most treatment-resistant cancers. A new study offers clues as to how it can aggressively resist immunotherapy.

The FDA has approved the use of sound waves to break down tumors—a technique called histotripsy—in humans for liver treatment.

A microdevice has been designed that can be implanted into tumors to conduct dozens of experiments at once to study the effects of new treatments on some of the hardest-to-treat brain cancers.

New findings indicate that epigenetic changes contribute to incurable brain tumors called gliomas.

A green tea compound shows promise for treating and even preventing uterine fibroids, according to a new pre-clinical study.

Glioblastoma is the most aggressive type of brain cancer, causing significant decline in cognitive function. New research suggests a common anti-seizure drug could help control tumor growth.